These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7610502)

  • 21. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Establishment of epithelial cell line TBC-27 from a human bladder transitional cell carcinoma and its biological characteristics].
    Liu CJ; Ma TX; Wang ZQ; Chang JW; Liu XB; Sui ZF; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):427-9, 21. PubMed ID: 3452540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol.
    Stearns ME; Wang M
    Oncol Res; 1994; 6(4-5):195-201. PubMed ID: 7841542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
    Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
    Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a newly established human urinary bladder cancer cell line (BT-1).
    Heckl W; Köhler J; Hoehn H; Dämmrich J
    Urol Res; 1988; 16(1):23-9. PubMed ID: 3344562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
    Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
    J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
    Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F
    Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a new human bladder cancer cell line, UCRU-BL-28.
    Russell PJ; Palavidis Z; Rozinova E; Philips J; Wills EJ; Lukeis R; Wass J; Raghavan D
    J Urol; 1993 Sep; 150(3):1038-44. PubMed ID: 8345582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9.
    Wu Q; Possati L; Montesi M; Gualandi F; Rimessi P; Morelli C; Trabanelli C; Barbanti-Brodano G
    Int J Cancer; 1996 Mar; 65(6):840-6. PubMed ID: 8631601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autocrine factor enhancing the secretion of M(r) 95,000 gelatinase (matrix metalloproteinase 9) in serum-free medium conditioned with murine metastatic colon carcinoma cells.
    Hyuga S; Nishikawa Y; Sakata K; Tanaka H; Yamagata S; Sugita K; Saga S; Matsuyama M; Shimizu S
    Cancer Res; 1994 Jul; 54(13):3611-6. PubMed ID: 8012988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
    Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine.
    Eissa S; Ali-Labib R; Swellam M; Bassiony M; Tash F; El-Zayat TM
    Eur Urol; 2007 Nov; 52(5):1388-96. PubMed ID: 17466450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.
    Canning MT; Postovit LM; Clarke SH; Graham CH
    Exp Cell Res; 2001 Jul; 267(1):88-94. PubMed ID: 11412041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
    Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
    Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines].
    Sumi S; Kihara K; Kageyama Y; Higashi Y; Fukui I; Oshima H
    Hinyokika Kiyo; 1990 Aug; 36(8):903-6; Discussion 906-7. PubMed ID: 1700590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and characterization of two cell lines derived from human transitional cell carcinoma.
    Chang J; Sui Z; Ma T; Ma K; Zhang X; Wang J; Dong K; Yao Q
    Chin Med J (Engl); 1995 Jul; 108(7):522-7. PubMed ID: 7555271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.